MENU
SMRI
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Mid-Cap Value
SMRI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Jul 31, 2026

Momentum Indicator for SMRI turns positive, indicating new upward trend

SMRI saw its Momentum Indicator move above the 0 level on July 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator turned positive. In of the 45 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SMRI just turned positive on July 27, 2026. Looking at past instances where SMRI's MACD turned positive, the stock continued to rise in of 30 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 218 cases where SMRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

SMRI broke above its upper Bollinger Band on July 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Applied Materials (NASDAQ:AMAT), Chevron Corp (NYSE:CVX), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), QUALCOMM (NASDAQ:QCOM), ConocoPhillips (NYSE:COP), Bristol-Myers Squibb Co (NYSE:BMY), McKesson Corp (NYSE:MCK), Newmont Corp (NYSE:NEM).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF ETF is 80.42B. The market cap for tickers in the group ranges from 10.21B to 644.29B. XOM holds the highest valuation in this group at 644.29B. The lowest valued company is MOH at 10.21B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF ETF was 3%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 24%. EXPE experienced the highest price growth at 13%, while QCOM experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was -24% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 38
Price Growth Rating: 36
SMR Rating: 52
Profit Risk Rating: 54
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapValue

Profile
Details
Category
Mid-Cap Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com
Momentum Indicator for SMRI turns positive, indicating new upward trend